Donald Winston Paty

Title: The Innovations of Donald Winston Paty

Introduction

Donald Winston Paty is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of medical research, particularly in relation to multiple sclerosis. With a total of 2 patents, his work focuses on innovative methods for diagnosing and monitoring the progression of this complex disease.

Latest Patents

Paty’s latest patents include groundbreaking methods for determining the status of multiple sclerosis patients. One of his inventions, titled "P-cresol sulfate, a component of urinary myelin basic protein-like material, as a correlate of multiple sclerosis status," provides a method for predicting the transition from relapsing-remitting to progressive phases of multiple sclerosis. This method involves measuring the amount of urinary p-cresol sulfate in patients. Additionally, he has developed a method for determining the amount of lesions and total lesion area in multiple sclerosis patients through similar measurements. Another patent focuses on monitoring myelination in developing children by measuring the levels of urinary myelin basic protein-like material.

Career Highlights

Donald Winston Paty is associated with the UAB Research Foundation, which is part of the University of Alabama at Birmingham. His work at this institution has allowed him to collaborate with other researchers and contribute to advancements in medical diagnostics.

Collaborations

Some of his notable coworkers include John Nicholas Whitaker and Robert David Kachelhofer. Their collaborative efforts have further enhanced the research and development of innovative solutions in the medical field.

Conclusion

Donald Winston Paty’s contributions to the field of medical research, particularly in relation to multiple sclerosis, highlight the importance of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced diagnostic methods.